Overexpression of cyclin D1 increases cyclin-dependent kinases 4 and 6 (CDK4/6) and stimulates cell division, making this pathway an attractive target in cancer therapy [100,101,102,103,104]. This evidence concerns the gene CDK4 and cancer.